Voyager Therapeutics Inc (NASDAQ: VYGR) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Voyager Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $9.91 and fluctuated between $10.31 as its day high and $9.68 as its day low. The current market capitalization of Voyager Therapeutics Inc is $538.11M. A total of 0.72 million shares were traded on the day, compared to an average of 1.01M shares.

In the most recent transaction, Sandrock Alfred sold 13,033 shares of VYGR for 7.46 per share on Feb 21 ’24. After the transaction, the President and CEO now owns 334,954 company shares. In a previous transaction on Feb 21 ’24, Swartz Robin sold 3,966 shares at 7.45 per share. VYGR shares that Chief Operating Officer owns now total 118,361.

Among the insiders who sold shares, PFREUNDSCHUH PETER P. disposed of 3,764 shares on Feb 21 ’24 at a per-share price of $7.46. This resulted in the Chief Financial Officer holding 175,669 shares of VYGR after the transaction. In another insider transaction, Carter Todd Alfred sold 3,365 shares at $7.47 per share on Feb 21 ’24. Company shares held by the Chief Scientific Officer now total 87,627.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VYGR has a high of $14.34 and a low of $6.06.

As of this writing, VYGR has an earnings estimate of -$0.44 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.52. The company reported an EPS of -$0.59 in the last quarter, which was -1.70% lower than expectations of -$0.58.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VYGR’s latest balance sheet shows that the firm has $132.54M in Cash & Short Term Investments as of fiscal 2021. There were $44.18M in debt and $50.98M in liabilities at the time. Its Book Value Per Share was $5.37, while its Total Shareholder’s Equity was $95.06M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VYGR is Buy with a score of 4.80.

Most Popular

Related Posts